The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Abstract
CONTEXT: Reasons for the shorter survival of black breast cancer patients compared with their white counterparts are not completely understood. OBJECTIVE: To evaluate the role of comorbidity in this racial disparity among breast cancer patients. DESIGN, SETTING, AND PATIENTS: Historical cohort from the Henry Ford Health System (a large comprehensive health system in Detroit, Mich) followed up for a median of 10 years. Patients (n = 906) included 264 black (29.1%) and 642 white (70.9%) women diagnosed as having breast cancer between 1985 and 1990. Detailed comorbidity data (268 comorbidities) and study data were abstracted from medical records and institutional, Surveillance, Epidemiology, and End Results, and Michigan State registries. Associations were analyzed with logistic and Cox regression. MAIN OUTCOME MEASURES: Breast cancer recurrence/progression and survival to death from all, breast cancer, and competing (non-breast cancer) causes. RESULTS: Of blacks, 64 (24.9%) died of breast cancer and 95 (37.0%) died of competing causes. Comparable data for whites were 115 (18.3%) and 202 (32.1%). Blacks had worse all-cause survival (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.11-1.62), breast cancer-specific survival (HR, 1.47; 95% CI, 1.08-2.00), and competing-causes survival (HR, 1.27; 95% CI, 1.00-1.63). A total of 77 adverse comorbidities were associated with reduced survival. Adverse comorbidity count was associated with all-cause (adjusted HR, 1.29; 95% CI, 1.19-1.40) and competing-causes survival but was not associated with recurrence/progression or breast cancer-specific survival. At least 1 adverse comorbidity was observed in 221 (86.0%) blacks and 407 (65.7%) whites (odds ratio, 3.20; 95% CI, 2.17-4.72). Comparisons of unadjusted and comorbidity-adjusted HRs indicated that adverse comorbidity explained 49.1% of all-cause and 76.7% of competing-causes survival disparity. Diabetes and hypertension were particularly important in explaining disparity. CONCLUSIONS: More black breast cancer patients die of competing causes than of breast cancer. Effective control of comorbidity in black breast cancer patients should help improve life expectancy and lead to a reduction in survival disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Health Measurement Scales: A Practical Guide to Their Development and Use
Streiner, D. L., Norman, G. R., & Cairney, J. (1989) · Cited by 9,595
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
Modeling and variable selection in epidemiologic analysis
Greenland, S. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.3.340 · Cited by 2,208
International Classification of Diseases, 10th Revision
(2018) · The SAGE Encyclopedia of Intellectual and Developmental Disorders · doi:10.4135/9781483392271.n276 · Cited by 1,917
A wilcoxon‐type test for trend
Cuzick, J. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040112 · Cited by 1,900
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 896
The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
Satariano, W. A., & Ragland, D. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-2-199401150-00002 · Cited by 731
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Principles of Exposure Measurement in Epidemiology
White, E., Armstrong, B. K., & Saracci, R. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198509851.001.0001 · Cited by 659
Race, Socioeconomic Status, and Breast Cancer Treatment and Survival
Bradley, C. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.490 · Cited by 658
Health measurement scales. A practical guide to their development and use, 3rd ed
Rajmil, L. (2005) · Europe PMC (PubMed Central) · Cited by 567
Eley, J. W. (1994) · JAMA · doi:10.1001/jama.1994.03520120057031 · Cited by 531
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V., Smith, R., & Thun, M. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 451
Impact of comorbidity on lung cancer survival
Tammemagi, C. M., Neslund‐Dudas, C., Simoff, M., & Kvale, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.10882 · Cited by 282
Self-citationSocial class and black-white differences in breast cancer survival.
Bassett, M. T., & Krieger, N. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.12.1400 · Cited by 243
Kieszak, S. M., Flanders, W. D., Kosinski, A. S., Shipp, C. C., & Karp, H. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00154-1 · Cited by 218
Effects of health insurance and race on breast carcinoma treatments and outcomes
Roetzheim, R. G., Gonzalez, E. C., Ferrante, J. M., Pal, N., Van Durme, D. J., & Krischer, J. P. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2202::aid-cncr8>3.0.co;2-l · Cited by 216
Race and socio-economic status in survival from breast cancer
Dayal, H. H., Power, R. N., & Chiu, C. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90020-0 · Cited by 207
Using administrative data to describe casemix: A comparison with the medical record
Malenka, D. J., McLerran, D., Roos, N., Fisher, E. S., & E.Wennberg, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90118-x · Cited by 166
Newschaffer, C. J., Bush, T. L., & Penberthy, L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00050-4 · Cited by 145
Chu, K. C., Lamar, C. A., & Freeman, H. P. (2003) · Cancer · doi:10.1002/cncr.11411 · Cited by 144
Tammemägi, M. C., Neslund-Dudas, C. M., Simoff, M., & Kvale, P. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.11.002 · Cited by 144
Race and Differences in Breast Cancer Survival in a Managed Care Population
Yood, M. U., Johnson, C. C., Blount, A., Abrams, J. S., Wolman, E., McCarthy, B. D., Raju, U., Nathanson, D. S., Worsham, M. J., & Wolman, S. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1487 · Cited by 143
Accuracy of administrative data to assess comorbidity in patients with heart disease
Powell, H. A., Lim, L. L.-Y., & Heller, R. F. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00364-4 · Cited by 140
Comorbidity and breast cancer survival: A comparison between black and white women
West, D. W., Satariano, W. A., Ragland, D. R., & Hiatt, R. A. (1996) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)00096-8 · Cited by 131
Preen, D. B., Holman, C. D. J., Lawrence, D. M., Baynham, N. J., & Semmens, J. B. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.016 · Cited by 124
African‐American/White differences in breast carcinoma
Jones, B. A., Kasl, S. V., Howe, C. L., Lachman, M. F., Dubrow, R., Curnen, M. G. M., Soler‐Vilá, H., Beeghly, A., Duan, F., & Owens, P. H. (2004) · Cancer · doi:10.1002/cncr.20500 · Cited by 113
Simon, M. S., & Severson, R. K. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70381-8 · Cited by 80
Ethnic differences in risk and prognostic factors for breast cancer
Weiss, S. E., Tartter, P. I., Ahmed, S., Brower, S. T., Brusco, C., Bossolt, K., Amberson, J. B., & Bratton, J. (1995) · Cancer · Cited by 73
Racial differences in the presentation and surgical management of breast cancer
Velanovich, V., Yood, M. U., Bawle, U., Nathanson, D. S., Strand, V. F., Talpos, G. B., Szymanski, W., & Lewis, F. R. (1999) · Surgery · doi:10.1016/s0039-6060(99)70004-8 · Cited by 58
The impact of comorbidity on the survival of postmenopausal women with breast cancer
Nagel, G., Wedding, U., Hoyer, H., R�hrig, B., & Katenkamp, D. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0594-3 · Cited by 56
Importance of race on breast cancer survival
Lyman, G. H., Kuderer, N. M., Lyman, S. L., et al. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02316814 · Cited by 51
Aging, Comorbidity, and Breast Cancer Survival: An Epidemiologic View
Satariano, W. A. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2926-2_1 · Cited by 46
Krieger, N., Eeden, S. K. V. D., Zava, D. T., & Okamoto, A. (1997) · PubMed · Cited by 46
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Metadata
- Authors
- Tammemagi, C. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-10-12
- Volume
- 294
- Issue
- 14
- Pages
- 1765
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2098203737
- Cited by
- 432
- References
- 41
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.